An Image for an Eye
This article was originally published in Start Up
Executive SummaryIn two dramatically different surgical markets, new technologies promise to improve visual access to difficult-to-reach places in the body. The first market builds on improvements in endoscopy, the second is driven by advances in diagnostic imaging.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.